[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"shoulder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:shoulder":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,46,75,105,131,159,184,206,231],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100540986","inhance-stemless-reverse-shoulder-ide-100540986",false,"NCT06323980","INHANCE Stemless Reverse Shoulder IDE","Randomized, Prospective, Multi-Center Study of the INHANCE Stemless Total Reverse Shoulder System","Inclusion Criteria:\n\n1. Individuals requiring reverse total shoulder replacement for a severely painful, disabling, arthritic joint (i.e. osteoarthritis, post-traumatic arthritis and rotator cuff arthropathy).\n2. Individuals who are anatomically and structurally suited to receive the implants and have a functional deltoid muscle.\n3. Individuals who are able to read and comprehend the informed patient consent document and are willing and able to provide informed patient consent for participation in the study and have authorized the transfer of their information to DePuy Synthes.\n4. Individuals who are willing and able to return for follow-up as specified by the study protocol.\n5. Individuals who are a minimum age of 22 years at the time of consent.\n6. Individuals who are willing and able to complete the Patient Reported Outcome Measure questionnaires (PROMs) as specified by the study protocol.\n\nExclusion Criteria:\n\n1. BMI \\> 40 kg\u002Fm2\n2. Individuals have active, uncontrolled local infection or systemic infection.\n3. Patients who have not reached skeletal maturity, regardless of age.\n4. Either preoperatively or intraoperatively and per standard of care medical assessment, bone stock in the proximal humerus or glenoid fossa is determined to be inadequate for supporting the INHANCE humeral stemless components (NOTE: exclusion applies to both arms of the study, i.e., bone stock to be evaluated independent of randomized treatment assignment).\n5. Intraoperatively and per treating physician's assessment of bone quality, bone is determined to be too soft or porous to support the implant or that is too hard or brittle to allow for proper bone preparation and fixation, i.e. osteoporosis or sclerotic bone, or tumor(s) of the supporting bone structure, where there could be considerable migration of the prosthesis and\u002For a chance of fracture of the humerus or glenoid.\n6. Fractures of the proximal humerus that could compromise the fixation of the INHANCE reverse humeral stemless components.\n7. Patients who have undergone previous treatment on the study shoulder that may compromise fixation of the INHANCE reverse humeral stemless component.\n8. Revision of a failed hemi, total or reverse shoulder arthroplasty.\n9. Patient is receiving, or is scheduled to receive, treatment that the Investigator considers could affect bone quality, such as chemotherapy or high dose corticosteroids.\n10. Individuals who are bedridden per the Investigator's determination.\n11. Individuals that have participated in a clinical investigation with an investigational product (drug or device) in the last three months.\n12. Individuals currently involved in any personal injury litigation, medical-legal or worker's compensation claims.\n13. Individuals, in the opinion of the Investigator, who are drug or alcohol abusers or have psychological disorders that could affect their ability to complete patient reported questionnaires or be compliant with follow-up requirements.\n14. Patients with a known medical condition that the Investigator believes would impact the study outcomes (including, but not limited to osteomyelitis, Paget's disease, neuropathies such as Charcot's disease, metastatic or neoplastic disorders).\n15. Patient has a medical condition with less than 2 years life expectancy.\n16. Patients who are known to be pregnant or breastfeeding.\n17. Known polyethylene and\u002For metal sensitivity or allergy.\n18. Contralateral side has been enrolled in the study or has received a total shoulder operation within the last 6 months\n19. Otherwise determined by the investigator to be medically unsuitable for participation in this study\n20. Patient is a member of a vulnerable population (i.e., incarcerated individuals - those incarcerated for at least one month and considered to be an inmate)","ALL","22 Years",{"count":19,"type":20},168,"ESTIMATED","INTERVENTIONAL",[23],"NA","2:1 Randomized, Controlled, Multi-Center, Prospective, Pre-Market Study of the INHANCE Stemless Reverse Cementless Total Shoulder.",[26,27,28],"Arthroplasty","Replacement","Shoulder",[30,31,32],"Reverse Shoulder","Stemless Shoulder","Total Shoulder","RECRUITING","2026-06-04",{"date":36,"type":37},"2026-06-05","ACTUAL",{"date":39,"type":37},"2025-03-04",{"date":41,"type":20},"2028-10-30",{"name":43,"class":44},"DePuy Orthopaedics","INDUSTRY",19,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":59,"conditions":60,"keywords":61,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":74},"100640227","sleep-and-functional-outcomes-after-reverse-shoulder-arthroplasty-100640227","NCT07582081","Sleep and Functional Outcomes After Reverse Shoulder Arthroplasty","Correlation Between Objective Sleep Parameters Measured by MotionWatch 8 and Functional Outcomes in Patients Undergoing Reverse Shoulder Arthroplasty: A Prospective Blinded Study","Sleep and RSA","Inclusion Criteria:\n\nPatients undergoing reverse shoulder arthroplasty Diagnosis of cuff arthropathy or glenohumeral osteoarthritis Age ≥18 years Ability to provide informed consent\n\nExclusion Criteria:\n\nRefusal to participate Known psychiatric disorders Pre-existing diagnosed sleep disorders or ongoing treatment for sleep disturbances Pathology affecting the contralateral shoulder Inability to comply with study protocol","18 Years","90 Years",{"count":57,"type":20},20,"OBSERVATIONAL","This prospective blinded study aims to investigate the relationship between objectively measured sleep parameters and patient-reported sleep and functional outcomes in patients undergoing reverse shoulder arthroplasty. Sleep will be assessed using MotionWatch 8, and outcomes will be correlated with validated clinical scores. This study is designed as a prospective, blinded clinical investigation conducted at a single tertiary referral center. Patients undergoing reverse shoulder arthroplasty for cuff arthropathy or glenohumeral osteoarthritis will be consecutively enrolled.\n\nObjective sleep parameters will be collected using MotionWatch 8 one week prior to surgery in the patients' home environment. Functional and subjective sleep assessments will be performed preoperatively using validated scoring systems including ASES, Constant-Murley Score, VAS, SST, PSQI, and Jenkins Sleep Scale.\n\nPostoperative follow-up will include reassessment of functional scores at 1, 3, and 6 months. At the 6-month follow-up, both subjective sleep assessments and objective sleep measurements will be repeated.\n\nThe primary objective is to evaluate the correlation between objective sleep parameters and ASES and PSQI scores.",[28],[62],"RSA, Sleep quality","NOT_YET_RECRUITING","2026-05-06",{"date":66,"type":37},"2026-05-12",{"date":68,"type":20},"2026-07-01",{"date":70,"type":20},"2027-07-01",{"name":72,"class":73},"Ankara City Hospital Bilkent","OTHER",1,{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":82,"sex":16,"minAge":54,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":21,"phases":85,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":74},"100632223","augmented-feedback-effects-on-shoulder-rotator-performance-100632223","NCT07510893","Augmented Feedback Effects on Shoulder Rotator Performance","Immediate and Retention Effects of Augmented Feedback on Isometric Peak Force and Rate of Force Development of Shoulder Rotators","Inclusion Criteria:\n\n* Healthy individuals aged between 18 and 30 years,\n* Body Mass Index (BMI) below 30 kg\u002Fm²,\n* An activity level of 5 or higher according to the Tegner Activity Scale,\n* Full active range of motion (ROM) in shoulder flexion, abduction, internal, and external rotation.\n\nExclusion Criteria:\n\n* Resence of current pain complaints,\n* Provocation of symptoms during at least one of the specific shoulder clinical tests (Neer Test, Hawkins-Kennedy Test, Jobe Test, Resisted External Rotation Test, and Apprehension Test),\n* History of any upper extremity injury, pain, or surgical intervention within the past 12 months,\n* Presence or history of hypertension, cardiovascular diseases, peripheral vascular diseases, deep vein thrombosis, neurological disorders, systemic inflammation, diabetes, cancer, or obesity,\n* Unwillingness to participate in the study.",true,"30 Years",{"count":57,"type":20},[23],"The existing literature demonstrates that motor learning strategies are effective in enhancing sports performance. One of these strategies, augmented feedback, is widely used in athletic training to help athletes achieve their goals more effectively, support the learning process, and motivate improvements in performance. Although studies in the literature have demonstrated the positive effects of augmented feedback provided during training on performance, no study has been found that examines the acute effects of such feedback on peak force and rate of force development during isometric training of the shoulder internal and external rotator muscles. The aim of this study is to investigate the acute effects of outcome feedback on isometric peak force and rate of force development during isometric training of the shoulder internal and external rotator muscles, as well as the short-term retention of these effects. It is expected that augmented feedback on isometric peak force and rate of force development, provided during isometric training of the shoulder internal and external rotator muscles, will have both acute and short-term retention effects on strength parameters. Healthy and physically active individuals will participate in isometric strength training targeting the dominant side shoulder internal and external rotator muscles across two separate sessions. Within a randomized crossover design, all participants will perform the isometric training program under two different conditions: with augmented feedback and without augmented feedback. The order of the conditions will be determined using a computer-based randomization program.To minimize potential learning effects, a washout period of 5-7 days will be provided between the two training conditions. Testing and training protocols will be conducted using an isometric dynamometer (ForceFrame, VALD Performance, Australia). The reported intraclass correlation coefficients (ICC) of the ForceFrame dynamometer for shoulder strength measurements range between 0.85 and 0.91, indicating good to excellent test-retest reliability. All testing and training procedures will be performed in accordance with the standard testing positions recommended by the manufacturer.",[88,89,28],"Performance Enhancement","Athlete",[91,92,93,94,28,95],"Motor learning","Rotator cuff","Muscle strength","Knowledge of result","Performance","2026-03-31",{"date":98,"type":37},"2026-04-06",{"date":100,"type":37},"2026-03-01",{"date":102,"type":20},"2026-11-01",{"name":104,"class":73},"Elif Turgut",{"id":106,"slug":107,"hasResults":11,"nctId":108,"briefTitle":109,"officialTitle":110,"acronym":4,"eligibilityCriteria":111,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":112,"enrollmentInfo":113,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":115,"conditions":116,"keywords":119,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":123,"lastUpdatePostDateStruct":124,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":129,"locationsCount":74},"100580511","ultrasonographic-analysis-of-post-traumatic-shoulder-lesions-after-hand-trauma-100580511","NCT06838247","Ultrasonographic Analysis of Post-Traumatic Shoulder Lesions After Hand Trauma","Detection of Simultaneous Presence of Shoulder Lesions in Patients With Hand Injuries by Diagnostic Ultrasonography","Inclusion Criteria:\n\n* Having a history of hand injury and applying for hand rehabilitation after surgical and conservative treatment.\n\nExclusion Criteria:\n\n* Being under 18 and over 65 years of age\n* Patients with systemic diseases (Diabetes mellitus, Peripheral vascular diseases)\n* Any rheumatic disease involving the hand and upper extremity\n* History of neuropathy involving the hand and upper extremity\n* Those with any shoulder problems prior to the hand injury\n* Those with an open wound on the hand\n* Those who cannot cooperate\n* Other upper extremity traumatic injuries occurring during the hand injury","65 Years",{"count":114,"type":20},60,"The purpose of the study is to reveal whether there are concurrent shoulder lesions in patients with hand injuries. Its importance is that it will shed light on whether not only the hand but also the shoulder should be included in the treatment program in hand rehabilitation.",[28,117,118],"Ultrasonographic","Hand Injuries",[120,28,121,122],"Hand injuries","Diagnostic","Ultrasonography","2026-03-19",{"date":125,"type":37},"2026-03-23",{"date":127,"type":37},"2024-11-11",{"date":68,"type":20},{"name":130,"class":73},"Ankara Training and Research Hospital",{"id":132,"slug":133,"hasResults":11,"nctId":134,"briefTitle":135,"officialTitle":136,"acronym":4,"eligibilityCriteria":137,"healthyVolunteers":11,"sex":138,"minAge":54,"maxAge":4,"enrollmentInfo":139,"targetDuration":4,"studyType":21,"phases":140,"briefSummary":141,"conditions":142,"keywords":146,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":150,"lastUpdatePostDateStruct":151,"startDateStruct":153,"completionDateStruct":155,"leadSponsor":157,"locationsCount":74},"100624227","reduction-of-bacterial-seeding-in-total-shoulder-arthroplasty-100624227","NCT07406893","Reduction of Bacterial Seeding in Total Shoulder Arthroplasty","Reduction of Bacterial Seeding in Total Shoulder Arthroplasty: Prontosan Antimicrobial Gel Incision Preparation Versus No Preparation in Male Patients","Inclusion Criteria:\n\n* Adult male 18 years of age or older undergoing elective primary total shoulder arthroplasty, including both anatomic and reverse total shoulder arthroplasty, for indications including massive rotator cuffs, rotator cuff arthropathy, glenohumeral osteoarthritis, and acute fractures.\n\nExclusion Criteria:\n\n* Any revision shoulder arthroplasty procedure or other shoulder surgery that is not a primary shoulder arthroplasty.\n* Patients with allergy to active ingredients in Prontosan gel\n* Patient is unable to consent for themselves\n* Patient is non-English speaking\n* Females","MALE",{"count":114,"type":20},[23],"The purpose of this study is to compare the growth of intra-operative tissue cultures of Cutibacterium Acnes after primary shoulder replacement when using a no-prep control group versus Prontosan wound gel applied to the skin layer after the skin incision has been made.",[143,28,144,145],"Joint Arthroplasty","Cutibacterium Acnes","Prosthetic Joint Infection",[147,148,149],"Antimicrobial wound gel","Dermal layer","Skin preparation","2026-03-06",{"date":152,"type":37},"2026-03-10",{"date":154,"type":37},"2026-02-23",{"date":156,"type":20},"2026-12",{"name":158,"class":73},"St. Louis University",{"id":160,"slug":161,"hasResults":11,"nctId":162,"briefTitle":163,"officialTitle":163,"acronym":4,"eligibilityCriteria":164,"healthyVolunteers":11,"sex":165,"minAge":166,"maxAge":167,"enrollmentInfo":168,"targetDuration":4,"studyType":21,"phases":169,"briefSummary":170,"conditions":171,"keywords":4,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":175,"lastUpdatePostDateStruct":176,"startDateStruct":178,"completionDateStruct":180,"leadSponsor":182,"locationsCount":74},"100594781","effect-of-kinetic-control-exercise-on-shoulder-dysfunction-post-mastectomy-100594781","NCT07023913","Effect of Kinetic Control Exercise on Shoulder Dysfunction Post Mastectomy","Inclusion Criteria:\n\nThe subject selection will be according to the following criteria:\n\n* Age from 40 to 50 years.\n* All patients have no diabetes or blood problems.\n* All patients enrolled to the study will have their informed consent.\n\nExclusion Criteria:\n\nThe potential participants will be excluded if they meet one of the following criteria:\n\n* Age less than 40 or more 50 years.\n* Diabetes mellitus.\n* Subjects with lymphedema\n* Subjects suffering from active malignant tumors.\n* Subjects treated with skin graft.\n* Subjects with Mental illness.\n* Subjects with skin diseases\n* Subjects with any previous cause for shoulder dysfunction","FEMALE","40 Years","50 Years",{"count":114,"type":20},[23],"The purpose of this study is to evaluate the effect of kinetic control exercises on shoulder dysfunction in post-mastectomy.",[172,173,28,174],"Kinetic Control","Dysfunction","Mastectomy","2025-06-14",{"date":177,"type":37},"2025-06-17",{"date":179,"type":20},"2025-06-15",{"date":181,"type":20},"2025-10-15",{"name":183,"class":73},"Cairo University",{"id":185,"slug":186,"hasResults":11,"nctId":187,"briefTitle":188,"officialTitle":189,"acronym":4,"eligibilityCriteria":190,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":4,"enrollmentInfo":191,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":192,"conditions":193,"keywords":194,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":198,"lastUpdatePostDateStruct":199,"startDateStruct":201,"completionDateStruct":203,"leadSponsor":204,"locationsCount":74},"100544664","prima-eu-retrospective--prospective-100544664","NCT06371833","PRIMA EU Retrospective & Prospective","A Multicentric Study Evaluating Clinical and Radiological Outcomes of PRIMA Humeral Stem in Total Shoulder Arthroplasty","Inclusion Criteria:\n\n1. Age ≥ 18 years old;\n2. Full skeletal maturity;\n3. Life expectancy over 24 months;\n4. Patient's joint anatomically and structurally suited to receive the selected implants and functional deltoid muscle;\n5. Patient meets at least one of the following indications:\n\n   For Anatomic configuration:\n   * non-inflammatory degenerative joint disease (i.e., osteoarthritis);\n   * inflammatory arthritis of the glenohumeral joint including rheumatoid arthritis;\n   * avascular necrosis of the humeral head;\n   * cuff tear arthropathy (CTA Heads only);\n\n   For Reverse configuration:\n   * rotator cuff tear arthropathy;\n   * osteoarthritiswith rotator cuff tear;\n   * rheumatoid arthritis with rotator cuff tear;\n   * massive irreparable rotator cuff tear;\n6. Patient is able to understand the conditions of the study, to comply with the prescribed rehabilitation as well as willing to perform all scheduled follow-up visits;\n7. Patient has signed the Informed Consent form previously approved by the Ethics Committee before study activities.\n\nExclusion Criteria:\n\n1. Patients who lack capacity to be able to provide informed consent to participate in the study.\n2. Local or systemic general infection;\n3. Septicaemia;\n4. Persistent acute or chronic local or systemic osteomyelitis;\n5. Confirmed neurologic lesion compromising shoulder joint function;\n6. Deltoid muscle insufficiency;\n7. Poor meta-epiphyseal bone stock compromising stability of the implant (severe fracture of the proximal humerus, meta-epiphyseal pseudoarthrosis, osteoporosis, osteomalacia, extended bone loss after previous prosthetic or non-prosthetic surgery);\n8. Affected by malignant cancer with life expectancy less than 2 years or where cancer treatment might affect the normal postoperative course;\n9. Serious muscular, neurological, or arterial vascular diseases compromising stability of the implant;\n10. Proximal humerus fracture sequelae with inadequate bone stock;\n11. Vascular or nerve diseases affecting the concerned limb;\n12. Metabolic disorders which may impair fixation and stability of the implant;\n13. Any concomitant disease that might affect the implanted prosthesis;\n14. Metal hypersensitivity to implant materials (CoCrMo);\n15. Patient with significant renal impairment;\n16. Lower mobility issues that may affect the study evaluation;\n17. Unwillingness or inability (due to physical or mental issues) to comply with rehabilitation and to return for follow-up visits and any psychiatric illness that would prevent comprehension of the details and nature of the study;\n18. Women of childbearing potential who are pregnant, nursing, or planning to become pregnant;\n19. Any clinically significant pathology based on the medical history that the Investigator feels may affect the study evaluation.",{"count":114,"type":20},"This clinical study aims at evaluating clinical, radiographic and patient-reported outcomes after total anatomic or reverse shoulder replacement using PRIMA humeral stem up to 24 months after surgery, in order to assess the short-term performance of the implant. Furthermore, the objective is also to collect short-term data on the survivorship of the implant and the incidence of complications.",[26,27,28],[195,196,197],"TSA","RSA","Shoulder replacement","2025-02-03",{"date":200,"type":37},"2025-02-05",{"date":202,"type":37},"2024-10-25",{"date":156,"type":20},{"name":205,"class":44},"Limacorporate S.p.a",{"id":207,"slug":208,"hasResults":11,"nctId":209,"briefTitle":210,"officialTitle":211,"acronym":212,"eligibilityCriteria":213,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":4,"enrollmentInfo":214,"targetDuration":4,"studyType":21,"phases":215,"briefSummary":216,"conditions":217,"keywords":219,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":222,"lastUpdatePostDateStruct":223,"startDateStruct":225,"completionDateStruct":227,"leadSponsor":229,"locationsCount":74},"100455744","effectiveness-of-focal-vibration-in-shoulder-pathology-100455744","NCT05214547","Effectiveness of Focal Vibration in Shoulder Pathology","Focal Vibration Therapy Effectiveness in the Treatment of Patients With Adhesive Capsulitis","FVinAC","Inclusion Criteria:\n\n* Patients aged \\> 18 years\n* Unilateral adhesive capsulitis of the shoulder\n* The symptom duration \\> 3 months\n* Shoulder pain\n* The limited glenohumeral joint active range of motion of greater than 50% in at least three specific movements among abduction, flexion, internal rotation, and external rotation\n\nExclusion Criteria:\n\n* Previous shoulder surgeries\n* Massive, minor, and major rotator cuff tears\n* Pain and muscle strength loss due to neurological causes\n* History or presence of malignancy\n* Osteoporosis\n* Diabetes",{"count":57,"type":20},[23],"We hypothesize that focal vibration therapy will reduce pain, increase the mobilization of the glenohumeral joint, and will improve functionality in patients with adhesive capsulitis.",[218,28],"Adhesive Capsulitis",[220,221],"Pain, Shoulder","Vibration","2024-06-11",{"date":224,"type":37},"2024-06-13",{"date":226,"type":37},"2022-02-25",{"date":228,"type":20},"2024-06-25",{"name":230,"class":73},"Bitlis Eren University",{"id":232,"slug":233,"hasResults":11,"nctId":234,"briefTitle":235,"officialTitle":236,"acronym":4,"eligibilityCriteria":237,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":238,"targetDuration":4,"studyType":21,"phases":240,"briefSummary":241,"conditions":242,"keywords":4,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":243,"lastUpdatePostDateStruct":244,"startDateStruct":246,"completionDateStruct":248,"leadSponsor":250,"locationsCount":4},"100377568","driving-after-shoulder-surgery-100377568","NCT04196218","Driving After Shoulder Surgery","Driving After Arthroscopic Rotator Cuff Repair or Shoulder Arthroplasty","Inclusion Criteria:\n\n1. Patients undergoing either Rotator Cuff Repair or Shoulder arthroplasty from participating surgeon\n2. Patients receiving physical therapy from ATI Patewood clinic\n3. Must be able and willing to complete all study assessments and to be followed for the full course of the study.\n4. Must be able to read, write and follow instructions in English.\n5. In the opinion of the investigator, is that they subject is competent to participate in study activities\n6. Prior to injury, patient was routinely driving.\n\nExclusion Criteria:\n\n1. Prior shoulder surgery in the last 90 day\n2. Individuals with a history of any underlying neurological conditions",{"count":239,"type":20},150,[23],"Patients undergoing a shoulder arthroplasty or rotator cuff repair will be enrolled in the study. Patients will be asked to undergo driving simulator assessments post-operatively in ATI Physical Therapy for up to 12 weeks after surgery in order to determine when it may be safe for them to return to driving. Additional assessments include patient-reported outcomes, range of motion, and strength measures, which are all standard of care. Study participation concludes when the patient passes the driving simulator test.",[28],"2023-12-18",{"date":245,"type":37},"2023-12-19",{"date":247,"type":20},"2025-12",{"date":249,"type":20},"2026-06",{"name":251,"class":73},"The Hawkins Foundation"]